**Figure 5. **Changes in angiogenesis- and inflammation-related genes in PSP-treated CNV corneas. Compared with controls, the expressions
of *VEGF*, *MMP2*, *MMP9*, *SDF1*, and *TNF* were reduced by 73%, 76%, 35%, 51%, and 64% respectively, while the expression of *PEDF* was increased by 76%. Red bars represent standard deviation, and blue bars represent a 95% confidence interval for the mean.